eGene Announced Appointment of New CFO
News Dec 02, 2005
eGene Inc. has announced the appointment of Peter Sheu as chief financial officer of eGene Inc. effective immediately.
Sheu has 15 years of experience in capital markets, corporate finance and technology sector.
Most recently, Sheu was chief financial officer of Simax Technologies Inc. Sheu has a Master of Science in Finance and a Master of Architecture degree from the University of Illinois at Urbana-Champaign.
"We are very pleased to welcome Peter to the eGene team," said Dr. Ming Liu, the CEO of eGene.
"Peter brings significant finance and management experience to the company which will be invaluable as eGene moves to the next phase of its growth."
"We look forward to Peter's contribution to our corporate finance, investor relations, financial reporting and management activities."
In treating inflammatory bowel disease (IBD), physicians can have a hard time telling which newly diagnosed patients have a high risk of severe inflammation or what therapies will be most effective. Now researchers report finding an epigenetic signature in patient cells that appears to predict inflammation risk in a serious type of IBD called Crohn’s disease.